Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CHINOOK THERAPEUTICS, INC. (KDNY)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 195.6% | 38.9% | 182.6% | | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | -95.6% | 61.1% | -82.6% | | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 2304.4% | 187.9% | 4359.3% | | 502.7% | 518.5% | 173.1% | 80.4% |
| General and administrative | 592.2% | 61.8% | 2306.0% | | 238.8% | 195.8% | 67.6% | 38.1% |
| EBITDA | -3018.2% | -175.1% | -6679.0% | | -612.5% | -594.4% | -136.8% | -17.6% |
| Depreciation | 27.0% | 2.7% | 68.9% | | 29.0% | 19.9% | 4.0% | 0.9% |
| EBITA | -3045.2% | -177.7% | -6747.9% | | -641.5% | -614.3% | -140.7% | -18.5% |
| Amortization of intangibles | 28.1% | 3.3% | 51.0% | | 3.9% | 3.2% | 1.1% | 0.1% |
| EBIT | -3020.3% | -177.8% | -6798.9% | | -645.4% | -617.5% | -141.8% | -18.6% |
| Pre-tax income | -2994.8% | -195.3% | -10111.9% | | -637.2% | -598.8% | -137.5% | -53.9% |
| Income taxes | 70.8% | 4.1% | -242.2% | | -5.2% | -65.9% | 42.4% | -0.1% |
| Net income | -3065.7% | -199.4% | -9869.6% | | -632.0% | -532.9% | -179.8% | -53.7% |
|